A Pharmaceutical Strategies Group survey finds employers and health plans prioritizing cost control and cross-benefit management, with growing willingness to trade rebates for stronger utilization oversight amid rising complexity and CGT concerns.
Out-of-pocket spending for covered drugs would count toward a patient's maximum out-of-pocket and deductible regardless of where such drugs are purchased under the Every Dollar Counts Act introduced by Rep. Greg Murphy, R-N.C.
New research from PwC highlights the extent of the employee financial wellness crisis, as 47% of Gen Xers say they will retire later than originally planned because they don't have enough saved.
